Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$32.31 - $52.32 $2.39 Million - $3.87 Million
74,030 New
74,030 $2.69 Million
Q1 2023

May 15, 2023

BUY
$46.97 - $58.27 $3.42 Million - $4.24 Million
72,793 Added 1319.67%
78,309 $3.8 Million
Q4 2022

Feb 14, 2023

BUY
$52.05 - $65.0 $287,107 - $358,540
5,516 New
5,516 $332,000
Q1 2022

May 16, 2022

SELL
$30.27 - $49.22 $199,963 - $325,147
-6,606 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$42.11 - $73.26 $278,178 - $483,955
6,606 New
6,606 $326,000
Q3 2021

Nov 15, 2021

SELL
$48.2 - $78.89 $1.25 Million - $2.04 Million
-25,886 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$21.63 - $57.65 $251,989 - $671,622
11,650 Added 81.83%
25,886 $1.33 Million
Q1 2021

May 17, 2021

SELL
$11.0 - $28.24 $39,193 - $100,619
-3,563 Reduced 20.02%
14,236 $358,000
Q4 2020

Feb 16, 2021

BUY
$10.12 - $13.94 $180,125 - $248,118
17,799 New
17,799 $214,000
Q3 2020

Nov 16, 2020

SELL
$9.93 - $13.47 $149,585 - $202,912
-15,064 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$9.56 - $12.51 $123,888 - $162,117
-12,959 Reduced 46.24%
15,064 $158,000
Q1 2020

May 15, 2020

SELL
$7.54 - $15.77 $457,497 - $956,860
-60,676 Reduced 68.41%
28,023 $300,000
Q4 2019

Feb 14, 2020

BUY
$7.48 - $17.01 $379,774 - $863,631
50,772 Added 133.87%
88,699 $1.4 Million
Q3 2019

Nov 14, 2019

SELL
$6.89 - $10.45 $755,977 - $1.15 Million
-109,721 Reduced 74.31%
37,927 $297,000
Q2 2019

Aug 14, 2019

BUY
$8.85 - $12.49 $900,682 - $1.27 Million
101,772 Added 221.84%
147,648 $1.56 Million
Q1 2019

May 15, 2019

BUY
$10.32 - $14.49 $288,082 - $404,488
27,915 Added 155.42%
45,876 $556,000
Q4 2018

Feb 14, 2019

SELL
$8.73 - $13.74 $316,881 - $498,734
-36,298 Reduced 66.9%
17,961 $185,000
Q3 2018

Nov 14, 2018

BUY
$12.7 - $15.79 $689,089 - $856,749
54,259 New
54,259 $710,000
Q4 2017

Feb 14, 2018

SELL
$35.44 - $63.76 $141,653 - $254,848
-3,997 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$53.83 - $67.75 $215,158 - $270,796
3,997
3,997 $259,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.